Bridging the Gap Between Participants and Clinical Trials

A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antiretroviral Activity of MK-1439 in HIV-1 Infected Patients

CONDITION

Inflammatory and Immune System

GENDER

Both males and females

AGE GROUP

From 18

and above

STATUS

Completed

Studies Contact Form

Name*
First Last
Email*
Phone Number
Message*
CAPTCHA
- Send me updates about clinical trials
This field is hidden when viewing the form
All
- All

Approved By: Belberry

Clinical Trial Registry Link: